Pancreatic carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Correction to: c-Src confers resistance to mitotic stress through inhibition of DMAP1/Bub3 complex formation in pancreatic cancer.
|
31783872 |
2019 |
Malignant neoplasm of pancreas
|
0.020 |
Biomarker
|
disease |
BEFREE |
Correction to: c-Src confers resistance to mitotic stress through inhibition of DMAP1/Bub3 complex formation in pancreatic cancer.
|
31783872 |
2019 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Blocking DMAP1 pTyr-246 potentiates paclitaxel-inhibited tumor growth.
|
30553276 |
2018 |
Pancreatic carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Clinically, DMAP1 Tyr 246 phosphorylation correlates with c-Src activity in human pancreatic cancer specimens and poor prognosis in pancreatic cancer patients.
|
30553276 |
2018 |
Malignant neoplasm of pancreas
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Clinically, DMAP1 Tyr 246 phosphorylation correlates with c-Src activity in human pancreatic cancer specimens and poor prognosis in pancreatic cancer patients.
|
30553276 |
2018 |
Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The anti-tumorigenic effect of MDGA2 was mediated through direct stabilising of DNA methyltransferase 1 associated protein 1 (DMAP1), which played a tumour suppressive role in gastric cancer.
|
26206665 |
2016 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Thus, epigenetic modification-related enzymes, such as DNA methyltransferases (DNMTs), histone methyltransferases (HMTs), histone demethylases (HDMTs), histone acetyltransferases (HATs), and histone deacetylases (HDACs), as well as some related proteins, including methyl-CpG binding proteins (MBPs) and DNMT1-associated protein (DMAP 1), are considered as potential targets for cancer prevention and therapy.
|
27697644 |
2016 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
Six out of twenty selected genes with largest expression difference (CYP1B1, GPT), genes linked to PCOS (RAB5B) or type 2 diabetes (PPARG, SVEP1), and methylation (DMAP1) were replicated in a separate case-control study.
|
26975253 |
2016 |
Malignant neoplasm of stomach
|
0.010 |
Biomarker
|
disease |
BEFREE |
The anti-tumorigenic effect of MDGA2 was mediated through direct stabilising of DNA methyltransferase 1 associated protein 1 (DMAP1), which played a tumour suppressive role in gastric cancer.
|
26206665 |
2016 |
Polycystic Ovary Syndrome
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
Six out of twenty selected genes with largest expression difference (CYP1B1, GPT), genes linked to PCOS (RAB5B) or type 2 diabetes (PPARG, SVEP1), and methylation (DMAP1) were replicated in a separate case-control study.
|
26975253 |
2016 |
Stomach Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The anti-tumorigenic effect of MDGA2 was mediated through direct stabilising of DNA methyltransferase 1 associated protein 1 (DMAP1), which played a tumour suppressive role in gastric cancer.
|
26206665 |
2016 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Thus, epigenetic modification-related enzymes, such as DNA methyltransferases (DNMTs), histone methyltransferases (HMTs), histone demethylases (HDMTs), histone acetyltransferases (HATs), and histone deacetylases (HDACs), as well as some related proteins, including methyl-CpG binding proteins (MBPs) and DNMT1-associated protein (DMAP 1), are considered as potential targets for cancer prevention and therapy.
|
27697644 |
2016 |